This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Geneart AG
Geneart AG, headquartered in Germany, is a leading player in the biotechnology industry, specialising in gene synthesis and related services. Founded in 2000, the company has established itself as a pioneer in custom DNA synthesis, catering to a diverse range of sectors including pharmaceuticals, agriculture, and synthetic biology. With a strong operational presence across Europe and North America, Geneart AG offers unique products such as GeneOptimizer® and GeneArt® GeneOptimizer® technology, which enhance the efficiency and reliability of gene synthesis. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner for researchers and companies seeking advanced genetic solutions. Notable achievements include collaborations with major biotech firms and contributions to significant scientific advancements, solidifying its reputation in the global market.
DitchCarbon Score
How does Geneart AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Geneart AG's score of 67 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Geneart AG, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Thermo Fisher Scientific Inc., which cascades its climate commitments and performance metrics down to Geneart AG. While Geneart AG does not have its own documented reduction targets, it aligns with the sustainability initiatives of Thermo Fisher Scientific Inc. This includes participation in the Science Based Targets initiative (SBTi) and other climate-related frameworks, which aim to drive significant reductions in greenhouse gas emissions across their operations. As part of its corporate family, Geneart AG benefits from the overarching climate strategies and performance metrics established by Thermo Fisher Scientific Inc., which is committed to reducing its carbon footprint and enhancing sustainability practices. However, specific details regarding Geneart AG's individual climate commitments or reduction targets remain unspecified. In summary, while Geneart AG does not provide its own emissions data or reduction targets, it is integrated into the broader sustainability efforts of Thermo Fisher Scientific Inc., reflecting a commitment to addressing climate change within its operational framework.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Geneart AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
